90133236 - FIBROBODIES

Information

• Trademark
• 90133236

• Source

• Serial Number

  90133236

• Registration Number

  6674974

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 24, 2020
  4 years ago

• Registration Date

  March 22, 2022
  3 years ago

• Transaction Date

  February 19, 2025
  3 months ago

• Status Date

  March 22, 2022
  3 years ago

• Published for Opposition Date

  August 24, 2021
  3 years ago

• Location Date

  March 22, 2022
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  DERBY, KAREN

• Attorney Docket Number

  KILB.00046.T

  Attorney Name

  Roberta S. Bren

  Law Office Assigned Location Code

  N50

• Owners

  • LINXIS B.V

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; Biochemical medicines for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for medical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; carrier excipients consisting of compounds that facilitate delivery of pharmaceutical preparations
• PM0001: FIBRO BODIES
• GS0011: Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease
• GS0441: Medical services, namely, in vitro analysis for medical and pharmaceutical use; Medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the Internet relating to pharmaceutical products
• GS0421: Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology

Case File Event Statements

• 8/27/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/26/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/19/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/27/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/27/2020 - 4 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/27/2020 - 4 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/4/2021 - 4 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/2/2021 - 3 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 6/4/2021 - 3 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/4/2021 - 3 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/20/2021 - 3 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/4/2021 - 3 years ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/24/2021 - 3 years ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/18/2022 - 3 years ago

  16 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR

• 8/24/2021 - 3 years ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/19/2021 - 3 years ago

  15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 1/18/2022 - 3 years ago

  18 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN

• 2/11/2022 - 3 years ago

  17 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 2/11/2022 - 3 years ago

  19 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B

• 3/22/2022 - 3 years ago

  20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/22/2024 - 9 months ago

  26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 8/22/2024 - 9 months ago

  24 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/22/2024 - 9 months ago

  23 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/22/2024 - 9 months ago

  25 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 2/19/2025 - 3 months ago

  27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 2/19/2025 - 3 months ago

  28 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 2/19/2025 - 3 months ago

  31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/19/2025 - 3 months ago

  29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 2/19/2025 - 3 months ago

  30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/22/2024 - 9 months ago

  21 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 8/22/2024 - 9 months ago

  22 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN